The store will not work correctly when cookies are disabled.
[2-(4-Methoxy-3-o-tolyl-quinolin-2-ylsulfanyl)-ethyl]-dimethyl-amine hydrochloride
ID: ALA543831
PubChem CID: 14001273
Max Phase: Preclinical
Molecular Formula: C21H25ClN2OS
Molecular Weight: 352.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1c(-c2ccccc2C)c(SCCN(C)C)nc2ccccc12.Cl
Standard InChI: InChI=1S/C21H24N2OS.ClH/c1-15-9-5-6-10-16(15)19-20(24-4)17-11-7-8-12-18(17)22-21(19)25-14-13-23(2)3;/h5-12H,13-14H2,1-4H3;1H
Standard InChI Key: YLBABHSTPCCLLD-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
5.0929 -1.1278 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9086 1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9091 -1.5019 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.9097 3.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2907 2.9981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.2025 -5.2568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9067 -3.0027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2071 0.7519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2049 -3.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8709 3.6035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2093 3.7519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2404 -5.8591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1622 -5.8549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3272 3.6028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5067 1.5010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5078 3.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 2 0
3 5 2 0
4 6 1 0
2 7 1 0
5 8 1 0
6 8 1 0
3 9 1 0
7 10 1 0
4 11 1 0
9 13 1 0
6 14 2 0
7 15 2 0
8 16 2 0
12 17 1 0
13 17 1 0
10 18 1 0
10 19 2 0
12 20 1 0
12 21 1 0
11 22 1 0
14 23 1 0
15 24 1 0
16 25 1 0
23 25 2 0
19 26 1 0
24 26 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 352.50 | Molecular Weight (Monoisotopic): 352.1609 | AlogP: 4.87 | #Rotatable Bonds: 6 |
Polar Surface Area: 25.36 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.45 | CX LogP: 5.12 | CX LogD: 4.03 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.59 | Np Likeness Score: -0.75 |
References
1. Blackburn TP, Cox B, Guildford AJ, Le Count DJ, Middlemiss DN, Pearce RJ, Thornber CW.. (1987) Synthesis and 5-hydroxytryptamine antagonist activity of 2-[[2-(dimethylamino)ethyl]thio]-3-phenylquinoline and its analogues., 30 (12): [PMID:3681895] [10.1021/jm00395a013] |